InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-1.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Hambleton Julie, Director. Insider active across 4 companies, notably SpringWorks Therapeutics, Inc.. Aggregated, 16 reports have been published. Breakdown: 1 buy · 6 sells. Total volume traded: €542k. History available since 20 May 2021. The latest transaction was filed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hambleton Julie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
2,000 sharesCommon StockSEC:0001415889-25-022042:0
14,155 sharesCommon StockSEC:0001104659-25-065315:0
10,060 shares0Common StockSEC:0001104659-25-049659:0
13,774 shares@ US$32.2762.3% of flowCommon StockSEC:0001104659-25-012362:0
15,132 shares@ US$1.394.6% of flowCommon StockSEC:0001415889-24-020266:0
2,946 shares@ US$39.413215.4% of flowCommon StockSEC:0001104659-24-068674:0
4,095 shares0Common StockSEC:0001104659-24-062979:0
2,418 shares@ US$29.31189.1% of flowCommon StockSEC:0001104659-23-083048:0
2,400 shares@ US$26.9188.5% of flowCommon StockSEC:0001104659-23-073743:0
4,648 shares0Common StockSEC:0001104659-23-064646:0
1,106 shares@ US$31.50214.7% of flowCommon StockSEC:0001104659-23-033345:0
4,818 shares0Common StockSEC:0001104659-22-063506:0
1,000 shares@ US$80.0031.2% of flowCommon StockSEC:0001209191-21-051011:0
6,000 shares@ US$16.00100.0% of flowCommon StockSEC:0000899243-21-029053:0
Canonical exit: 18 Oct 2021 (T+90)
2,000 shares@ US$80.0059.9% of flowCommon StockSEC:0001209191-21-038002:0
1,106 shares0Common StockSEC:0001104659-21-070518:0
16 of 16 declarations
About Hambleton Julie
Julie Hambleton is Administrateur and has 16 filings in total. Across the 16 recorded filings from 2021-05-21 to 2025-08-14, the recent filings show EUR 81,466 of buys and EUR 460,450 of sells, with the modal transaction nature listed as Cession. She is linked to SpringWorks Therapeutics, Inc., IGM Biosciences, Inc. and Erasca, Inc., all listed on XNAS.
